{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:16Z","timestamp":1755216796324,"version":"3.43.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Although thiopurine is a crucial drug for treating acute lymphoblastic leukemia, individual variations in intolerance are observed due to gene polymorphisms. A 3-year-old boy with B-cell precursor acute lymphoblastic leukemia who was administered thiopurine developed mucositis, sepsis, and hemophagocytic lymphohistiocytosis due to prolonged hematologic toxicity, chronic disseminated candidiasis, and infective endocarditis that triggered multiple brain infarctions. The patient was found to harbor 3 gene polymorphisms associated with thiopurine intolerance including homozygous <jats:italic toggle=\"yes\">NUDT15<\/jats:italic> R139C, heterozygous <jats:italic toggle=\"yes\">ITPA<\/jats:italic> C94A, and homozygous <jats:italic toggle=\"yes\">MTHFR<\/jats:italic> C677T and heterozygous <jats:italic toggle=\"yes\">RFC1<\/jats:italic> G80A. Thus, the combined effect of intolerance via multiple gene polymorphisms should be considered in case of unexpected adverse reactions.<\/jats:p>","DOI":"10.1097\/mph.0000000000002085","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:34:06Z","timestamp":1614386046000},"page":"e1173-e1176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association of Multiple Gene Polymorphisms Including Homozygous NUDT15 R139C With Thiopurine Intolerance During the Treatment of Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"43","author":[{"given":"Ko","family":"Kudo","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yuzawa","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akie","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kamio","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shimada","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Otani","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Tusjimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development"},{"name":"Department of Transplantation and Cell Therapy, Children\u2019s Cancer Center, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Toki","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[{"name":"Community Medicine, Hirosaki University Graduate School of Medicine, Hirosaki"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM199007053230104","article-title":"Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children","volume":"323","author":"Koren","year":"1990","journal-title":"N Engl J Med"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0140-6736(93)93168-Z","article-title":"Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient","volume":"341","author":"McLeod","year":"1993","journal-title":"Lancet"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817.409k04_2817_2823","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia","volume":"93","author":"Relling","year":"1999","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat Genet"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J Clin Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat Genet"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood-2017-05-782383","article-title":"Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry","volume":"130","author":"Moriyama","year":"2017","journal-title":"Blood"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.13518","article-title":"Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia","volume":"171","author":"Tanaka","year":"2015","journal-title":"Br J Haematol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41375-018-0190-1","article-title":"Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms","volume":"32","author":"Tsujimoto","year":"2018","journal-title":"Leukemia"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fphar.2019.00916","article-title":"ITPA, TPMT, and NUDT15 genetic polymorphisms predict 6-mercaptopurine toxicity in middle eastern children with acute lymphoblastic leukemia","volume":"10","author":"Moradveisi","year":"2019","journal-title":"Front Pharmacol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00280-018-3732-3","article-title":"Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia","volume":"83","author":"Khera","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bjh.14532","article-title":"TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay","volume":"181","author":"Soler","year":"2018","journal-title":"Br J Haematol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jjco\/hyy071","article-title":"Phase II\/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan","volume":"48","author":"Koh","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"30244","DOI":"10.1038\/srep30244","article-title":"PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy","volume":"6","author":"Smid","year":"2016","journal-title":"Sci Rep"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.leukres.2011.11.015","article-title":"The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children","volume":"36","author":"Tanaka","year":"2012","journal-title":"Leuk Res"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPH.0b013e318165b25d","article-title":"Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma","volume":"30","author":"Shimasaki","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"e27915","DOI":"10.1002\/pbc.27915","article-title":"Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003-2013","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1182\/blood-2008-11-187880","article-title":"Methotrexate\/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study","volume":"113","author":"Schmiegelow","year":"2009","journal-title":"Blood"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2017-11-815506","article-title":"Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy","volume":"131","author":"Nishii","year":"2018","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:00:13Z","timestamp":1754341213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002085","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"2020-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}